Name:

Email Address:

Address, City, State, Zip:

Main / Home Phone:

Second Phone Number:

Comments:

Diagnosis:

Mesothelioma Asbestosis Lung Cancer Other No Diagnosis

Purpose: The purpose of this trial is to:

• Assess the maximum dose of treatment that can be safely administered to patients with advanced malignancies
• Monitor and evaluate response to treatment
• Determine the effects of the drug upon test group

Eligibility: To be eligible to join this clinical trial you must:

• Have histologically confirmed malignancy (e.g. malignant mesothelioma)
• Have experienced recurrence following anti-cancer therapy or be unwilling to receive standard therapy
• Have a disease that can be measured or evaluated
• Not have any CNS or spinal involvement
• Not have had significant pericardial effusion
• Not have had hematopoietic growth factor therapy for at least one week
• Not have had anti-tumour therapy for at least four weeks
• Be 18 years of age or over
• Have life expectancy of at least three months

Due to the nature of this trial and the fact that it is designed for sufferers of advanced cancer, there is a very strict eligibility criterion.

Click Here To Return To The
Mesothelioma Clinical Trial Abstracts Overview Page.